Adapalene Products Market Size, Trends, Shares, Insights and Forecast – 2020-2027

1. ADAPALENE PRODUCTS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Adapalene Products Market - Overview The global Adapalene Products Market is expected to witness significant growth over the forecast period, owing to increasing approval of adapalene products by the regulatory authorities such as U.S. Food Drug and Administration (FDA). For instance, in 2016, Differin gel 0.1% (Galderma Laboratories company product) was approved by U.S Food Drug and Administration (FDA) for over the counter (OCT) treatment of acne. Differin gel 0.1% is approved for patients who are 12 years and above. Adapalene is a medication, which is used to treat mild to moderate acne. Moreover, adapalene reduces the deposition of the keratin in skin and hence this helps in the effective treatment for keratosis pilaris and callus. Additionally, adapalene suppress the inflammatory response and inhibit lipoxygenase activity and oxidative metabolism of arachidonic acid into prostaglandins, therefore, adapalene is used as an anti-inflammatory agent. Adapalene can be used in combination with benzoyl peroxide as well as with antimicrobial agent such as clindamycin to enhance the maximum efficiency for the treatment. Adapalene is available under the brand name of Differin and in different forms such as cream, gel, and lotion. In the U.S., adapalene is available in three different preparation that include 0.1% cream, 0.1% gel, and 0.3% gel, while only 0.1% cream and 0.1% gel are available in Europe. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/adapalene-products-market-4144 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Adapalene is generally used daily once during bedtime and are not applicable to the skin that is sunburned, or broken and until the skin has healed. Adapalene should not be used by the pregnant women, as drug is absorbed through the skin and can be harmful for the unborn baby. Furthermore, rising prevalence of skin related problems such as acne among populace is another factor that is expected to drive global adapalene products market growth. For instance, according to the National Center for Biotechnology Information(NCBI) 2019 report, out of 100 about 15 to 30 teenagers are suffering from the moderate to severe acne and is mostly found in females, in comparison to male. Moreover, availability of less expensive adapalene is the factor that is expected to boost the global adapalene products market growth over the forecast period. For instance, for a 45 g tube, average cost of the prescribed only branded Differin gel 0.1% is US$ 300, while the average cost of the prescribed only generic adapalene0.1% gel is US$ 150. Global Adapalene Products Market Restraints However, side effects associated with the adapalene such as skin discoloration, red skin, contact dermatitis, and intense burning sensation are expected to hamper the global adapalene products market growth over the forecast period. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4144 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Global Adapalene Products Market Regional Analysis Among regions, North America is expected to account for highest market share in the global adapalene products market over the forecast period, owing to increasing launches of adapalene products such as Epiduo for the topical treatment of acne vulgaris. For instance, in 2017, Teva Pharmaceutical Industries Ltd. launched generic Epiduo gel, which contains 0.1% adapalene and 2.5% benzoyl peroxide. Epiduo gel is used for the treatment of acne vulgaris and is applicable for patients who are of 9 years old or above. Moreover, Europe is expected to exhibit highest CAGR over the forecast period due to the increasing launches of adapalene products for the treatment of acne in the region. For instance, in September 2019, La Roche-Posay Laboratoire Pharmaceutique launched Effaclar Adapalene gel 0.1%, which is used in the treatment of acne. From the same source, in 2019, La Roche- Posay Laboratoire Pharmaceutique also launched My Skin Track PoreScan, which is artificial intelligence-based skin app to analyze skin acne, which in turn, is expected to drive demand for adapalene products in the market. Key players operating in the global adapalene products market include Galderma Laboratories LP, Teva Pharmaceutical Industries Ltd., Finorga SA, La Roche-Posay Laboratoire Pharmaceutique, Sandoz, Excella GmbH & Co. KG, Shionogi & Company, Limited, Johnson & Johnson, Stiefel Laboratories, and Niksan Pharmaceutical. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4144 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved